why choose us

Clinical Trials Search

Showing 15,480 of 132,963 result(s)
Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study

Status: Active, not recruiting

Condition: Diabetes Mellitus, Type 2
Cognitive Dysfunction
Gut Microbiota

Interventions: Other: whether the participants had T2DM
whether the participants had T2DM

Date: 2023-02-06

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

Status: Completed

Condition: Clear Cell Renal Cell Carcinoma

Interventions: Interventional

Date: 2023-02-06

Poul Gjessing Versus T Loops for Orthodontic Maxillary Canine Retraction

Status: Active, not recruiting

Condition: Canine Retraction

Interventions: Interventional

Date: 2023-02-06

Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients

Status: Completed

Condition: Post-COVID Syndrome

Interventions: Interventional

Date: 2023-02-06

Vertical Soft Tissue Augmentation With CTG vs ADM

Status: Completed

Condition: Implant Complication

Interventions: Vertical soft tissue augmentation with autogenous connective tissue graft (CTG)

Date: 2023-02-06

Investigating the Metabolic Pathways in Hormone Receptor Positive;HER2 Negative Breast Cancer

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: Discover new insights into the glucose, TCA cycle, amino acid, and lipid metabolic dependencies of HR+;Her2- breast cancer, via liquid chromatogr

Date: 2023-02-06

Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia

Status: Completed

Condition: Waldenstrom Macroglobulinemia

Interventions: Noncovalent Bruton Tyrosine Kinase (BTK) inhibitor, tablet taken orally.

Date: 2023-02-06

Social Workers Addressing Firearm Risk

Status: Completed

Condition: Gun Violence Prevention

Interventions: Educational intervention for social workers.

Date: 2023-02-06

Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED

Status: Completed

Condition: Persistent Corneal Epithelial Defect

Interventions: KPI-012 is a secretome product composed of biologically active components secreted from human bone marrow-derived mesenchymal stem cells

Date: 2023-02-06